ROLLINS JOHN WOODSON enters 20/20 BIOLABS, INC. with 11.11K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives

ROLLINS JOHN WOODSON

Filed: 2/23/2026ACC: 0001213900-26-019420

InsiderROLLINS JOHN WOODSONCIK 2112941

→

Issuer20/20 BIOLABS, INC.CIK 1139685

Director

Since Feb 2026

11.11K

Baseline shares

100% direct

11.11K

Direct ownership

1 position

279.74K

Derivative underlying

8 instruments

Security positions

All direct

Non-Derivative Holdings1

Common Stock

Direct

Shares owned11.11K

Total

11.11K direct11.11K

Security Title	Shares Owned	Ownership Type
Common Stock	11.11K	Direct
Total	11.11K	11.11K direct

Derivative Holdings8

Stock Option

Direct

Underlying security

Common Stock

Underlying shares

30K

Shares owned

N/A

Exercise price

2.55

Expiration

—

Exercise window

—

Stock Option

Direct

Underlying security

Common Stock

Underlying shares

76.63K

Shares owned

N/A

Exercise price

1.044

Expiration

—

Exercise window

—

Stock Option

Direct

Underlying security

Common Stock

Underlying shares

30K

Shares owned

N/A

Exercise price

1.74

Expiration

—

Exercise window

—

Stock Option

Direct

Underlying security

Common Stock

Underlying shares

48.78K

Shares owned

N/A

Exercise price

0.82

Expiration

—

Exercise window

—

Stock Option

Direct

Underlying security

Common Stock

Underlying shares

37.58K

Shares owned

N/A

Exercise price

1.0643

Expiration

—

Exercise window

—

Stock Option

Direct

Underlying security

Common Stock

Underlying shares

37.58K

Shares owned

N/A

Exercise price

1.0643

Expiration

—

Exercise window

—

Series A Preferred Stock

Direct

Underlying security

Common Stock

Underlying shares

13.03K

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Series A-2 Preferred Stock

Direct

Underlying security

Common Stock

Underlying shares

6.13K

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Total

Underlying

279.74K

Owned

0.00

Security	Underlying	Exercise Price	Exercise Window	Expiration	Underlying Shares	Shares Owned
Stock Option Direct	Common Stock	2.55	—	—	30K	N/A
Stock Option Direct	Common Stock	1.044	—	—	76.63K	N/A
Stock Option Direct	Common Stock	1.74	—	—	30K	N/A
Stock Option Direct	Common Stock	0.82	—	—	48.78K	N/A
Stock Option Direct	Common Stock	1.0643	—	—	37.58K	N/A
Stock Option Direct	Common Stock	1.0643	—	—	37.58K	N/A
Series A Preferred Stock Direct	Common Stock		—	—	13.03K	N/A
Series A-2 Preferred Stock Direct	Common Stock		—	—	6.13K	N/A
Total					279.74K	0.00